top of page
Frequently asked questions
FAQ
Parmorcan® offers CBD, CBG and CBN products made with hemp distillates and organic MCT oil. The range includes full-spectrum and broad-spectrum CBD products, broad-spectrum CBG and CBN products, and two- and three-bottle packs. The CBD–CBN formulation with lavender and chamomile is a separate product.The specific composition, declared cannabinoid content and volume are shown on each product page. For a transparent comparison, you can cross-check these details against the corresponding laboratory reports. The terms ‘organic’, ‘full-spectrum’ and ‘broad-spectrum’ do not replace product-specific evidence.
Yes. Parmorcan® provides links to laboratory reports for CBD, CBG and CBN and for the CBD–CBN formulation with lavender and chamomile. You can consult the documented laboratory reports for more information.
Dipl.-Chem. Mohammad Reza Talebnasab is the owner of Parmorcan®. He is personally responsible for formulation development, production and quality assurance, as well as editing our educational content.To assess a particular product, refer to its composition, labelling and the corresponding laboratory report.
Compare more than just the percentage. Check these six details on each product page:Cannabinoid: Is CBD, CBG or CBN listed? These names refer to different substances.Content: Check the declared cannabinoid content. A higher percentage alone is not comprehensive evidence of quality.Spectrum: Distinguish between full-spectrum and broad-spectrum products. For THC, the specific product information and corresponding analysis are decisive.Ingredients: Check the carrier oil and other ingredients listed in the product description.Volume: Compare the millilitres per bottle and the number of bottles. For sets, the percentages apply to each individual bottle and are not added together to produce an overall concentration.Laboratory report: Check the sample name, batch identification, test date, units and the parameters actually tested.Further information is available in the full-spectrum / broad-spectrum comparison and in the laboratory reports. An analytical report alone does not establish a health benefit or the complete safety of a product.
Parmorcan® CBD, CBG and CBN bundles contain two or three 10 ml products: 20 ml in total in a two-bottle pack or 30 ml in a three-bottle pack. The percentages refer to each individual product and are not added together.By contrast, the CBD–CBN formulation with lavender and chamomile is a separate product: one 10 ml bottle contains 20% CBD from full-spectrum distillate, 10% CBN from broad-spectrum distillate, and lavender and chamomile essential oils. It is not a two-bottle pack.Compare bundles · View the lavender and chamomile formulation
On the same measurement basis, 30% CBD denotes a higher declared CBD content than 20% CBD. However, the percentage describes neither the complete cannabinoid profile nor the quality of a product on its own. Also compare the spectrum, ingredients, volume and corresponding laboratory reports.Parmorcan® offers full-spectrum CBD distillates with 20% and 30% CBD and a broad-spectrum CBD distillate with 20% CBD, each as an individual 10 ml product. You can compare the variants under Full-spectrum CBD and Broad-spectrum CBD. Our guide to analytical units explains percentages and mg values.
In the Parmorcan® individual products described this way, hemp distillate is combined with organic MCT oil derived from coconut oil as the carrier oil. The finished CBD, CBG or CBN oil is therefore not equivalent to undiluted hemp distillate.The term ‘distillate’ alone specifies neither the cannabinoid spectrum nor the declared content. Both, along with the full composition, are shown on the individual product page. Our full-spectrum / broad-spectrum comparison and the laboratory reports help put these details into context.
No. Hemp seed oil is obtained from hemp seeds. The seeds do not naturally produce CBD; contact with other parts of the plant during processing can introduce small traces of cannabinoids. This does not make hemp seed oil a CBD oil with a defined CBD content.The term CBD oil generally refers to preparations combining CBD or a CBD-containing extract with a carrier oil. This carrier oil may, for example, be MCT oil or hemp seed oil. ‘Hemp oil’ alone therefore does not unambiguously specify the CBD content. The ingredients list, declared cannabinoid content and product-specific analytical data are decisive.Source: FDA on hemp seeds and cannabinoidsFurther reading: Hemp oil, hemp seed oil and CBD oil: reading labels correctly.
The carrier oil forms the oily base of the preparation. CBD is fat-soluble and poorly soluble in water; suitable oil bases allow it to be formulated in an oil mixture. The carrier oil is distinct from the hemp extract or cannabinoid itself.According to the product descriptions, Parmorcan® oils use organic MCT oil. MCT stands for medium-chain triglycerides, a particular group of fats. Naming the carrier oil describes one ingredient in the formulation. On its own, it establishes neither a greater health benefit nor clinical superiority of the product.Source: research on formulating CBD in lipid carriers
What matters is what the claim refers to: a particular raw material, a processing step or the finished product. Evidence for an individual ingredient does not automatically certify the entire formulation or business. The expressly stated scope and the associated evidence are decisive.The EU organic logo is subject to specific rules and is not intended for every product category. For example, it must not be used on cosmetics. Organic claims and cannabinoid analyses also answer different questions: a cannabinoid laboratory report does not replace organic certification, and an organic claim does not replace an analysis of composition.Source: European Commission on the organic logo and its scope
Follow the specific manufacturer's storage and shelf-life information on the label and packaging. A scientific study of CBD stability shows that the formulation studied and the storage conditions must be taken into account. Findings for CBD powder or a particular oil solution do not automatically apply to every other formulation.A general study therefore cannot establish a universal shelf life for all CBD, CBG or CBN oils. An additional period after opening should only be stated if it is specified or substantiated for the particular product. If the information is unclear, you can contact us with the product name and batch number.Source: original study of CBD stabilityAsk a product-specific question
Orders within Germany are sent by DHL with insured shipping. Parmorcan® offers free shipping within Germany.
Yes. The shipping page provides delivery times and tracking information, so you can keep track of your order.
The health and lifestyle consultation provides information about nutrition and lifestyle. Its purpose is to explain connections in an understandable way.
The website contains articles about CBD, CBG, CBN and other cannabinoid-related topics. You can also contact Support with questions about the range or scientific studies.
Yes. Non-intoxicating does not mean free of adverse effects. For the prescription CBD medicine Epidyolex, documented adverse effects include sleepiness, diarrhoea, decreased appetite and increased liver enzyme levels.These medicine data do not provide a general estimate of how often adverse effects occur with other CBD products. They do, however, show that CBD is pharmacologically active and must not be considered inherently risk-free. Health-related questions should be discussed with a doctor or pharmacist.Source: EMA overview of EpidyolexMore about CBD and the limitations of the research
CBD can affect enzymes that process medicines. For example, inhibition of CYP2C19 is documented for the CBD medicine. This can slow the breakdown of certain medicines and cause them to accumulate more in the blood during continued regular use. This can increase adverse effects and may be dangerous.The direction of the effect is not always the same. Some medicines first need to form an active metabolite; inhibition may then reduce their effect. The specific medicine and individual circumstances are decisive. Ask your doctor or pharmacist to assess combinations, and do not change prescribed medicines on your own.Source: CBD prescribing information, drug interactions sectionIn depth: cannabinoids and medicines – understanding interactions
An authorised medicine is assessed for quality, efficacy and safety for defined medical indications. Epidyolex is a prescription CBD medicine for certain forms of epilepsy and is used under medical supervision.Another product does not become an equivalent medicine simply because it also contains CBD. Composition, manufacturing and the conditions studied may differ. A study of a medicine therefore cannot substantiate an equivalent therapeutic or efficacy claim for a shop product.Source: EMA on the authorised CBD medicine EpidyolexCBD knowledge and scientific context
Human studies to date do not show a consistent picture. In a study published in 2024, some subjective sleep measures improved, while the primary sleep-quality outcome did not improve statistically significantly compared with placebo. A small sleep-laboratory study published in 2026 likewise found no statistically significant benefit for its primary outcome, objectively measured wake after sleep onset; some other measures changed.Such findings provide avenues for research, but do not establish that sleep disorders can be reliably treated. Different preparations, short study periods and limited participant numbers restrict generalisability. They do not establish an effect of Parmorcan® products.Original study: Bonn-Miller et al. (2024)Original study: Lavender et al. (2026)A closer look at CBN research
bottom of page